Advertisement
Silverback Therapeutics I... (SBTX)
NASDAQ: SBTX
· Real-Time Price · USD
5.87
0.06 (1.03%)
At close: Nov 09, 2022, 5:00 AM
1.03% (1D)
| Bid | n/a |
| Market Cap | 550.43M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -14.69M |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | 0 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 116,690 |
| Avg. Volume (20D) | 171,415 |
| Open | 5.82 |
| Previous Close | 5.81 |
| Day's Range | 5.82 - 6.15 |
| 52-Week Range | 2.80 - 7.54 |
| Beta | 0.00 |
About SBTX
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington....
Industry Biotechnology
Sector Healthcare
IPO Date Dec 3, 2020
Employees 90
Stock Exchange NASDAQ
Ticker Symbol SBTX
Website https://www.silverbacktx.com